SCHEMBL3207477

SCHEMBL3207477

CC(C)(C)c1ccc(S(=O)(=O)C2CCN(c3ccc(C(F)(F)F)cn3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.61
KDM4E B2RXH2 3/20 0.54
ABL1 P00519 1/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.49
DGAT1 O75907 1/20 0.49
CXCR3 P49682 2/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 3/20 0.47
CYP3A4 P08684 1/20 0.47
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
CA4 P22748 2/20 0.47
CA7 P43166 2/20 0.47
TRPV1 Q8NER1 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207424 0.88 L3MBTL1 (0.63) GPR119KDM4EABL1LMNAGAA
SCHEMBL3219201 0.84 MAPT (0.50) GPR119KDM4EDGAT1CXCR3ALDH1A1
SCHEMBL3216395 0.83 GPR119 (0.55) GPR119KDM4EABL1LMNAGAA
SCHEMBL3213659 0.82 LMNA (0.56) GPR119KDM4EABL1LMNAGAA
SCHEMBL3218002 0.80 GPR119 (0.52) GPR119KDM4EABL1LMNAGAA
SCHEMBL14349208 0.77 GPR119 (0.49) GPR119KDM4EABL1LMNAGAA
SCHEMBL3219566 0.76 HSD11B1 (0.70) TRPV1
SCHEMBL27683374 0.76 GPR119 (0.48) GPR119KDM4EABL1LMNAGAA
SCHEMBL10316049 0.76 GPR119 (1.00) GPR119KDM4EABL1LMNAGAA
SCHEMBL3201929 0.76 PDE10A (0.53) KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 GPR119 626/4885KDM4E 1296/4885ABL1 4341/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 GPR119 600/4885KDM4E 1360/4885ABL1 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.